Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FB825 in adults with atopic dermatitis
NCT03758716Phase 2Completed
- Sponsor
- Fountain Biopharma Inc.
- Start
- Jul 2017
- Primary completion
- Jan 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of FB825 in atopic dermatitis (AD), sponsored by Fountain Biopharma Inc.. Started Jul 2017; status: completed.
02
Drugs
FB825
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03758716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03758716.